[Personal experiences with conservative treatment of central retinal degeneration].
21 patients (40 eyes) aged 27-84 years (15 women and 6 men) were treated orally with cavinton 3 x 5 mg, sadamine++ 3 X 75 mg, cinnarizine++ 3 X 40 mg, vit. A+E 3 X 1 caps. daily. Intramuscularly++ were given vit. B1 25 mg, vit. B12 1000 micrograms, geriocaine++ 100 mg, and not in all sadamine++ 300 mg daily. Improvement of visual acuity for distance was observed in 31 eyes (77.5%) and for near vision in 17 eyes (42.5%). Within 34 eyes with visual field abnormalities in 9 the central or pericentral scotomas were observed. After medical treatment the central scotomas were diminished in 6 eyes (66.6%) and the enlargement of peripheral visual border from 10 to 30 degree in 10 eyes (40%) were observed.
Pojda
S M
SM
II Kliniki Okulistycznej AM w Bytomiu.
Bandych-Biniszkiewiczowa
D
D
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002936:Cinnarizine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008268:Macular Degeneration / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011343:Procaine / Q000008:administration & dosage*; D014748:Vinca Alkaloids / Q000008:administration & dosage*; D014792:Visual Acuity / Q000187:drug effects / Q000502:physiology; D014815:Vitamins / Q000008:administration & dosage*; D014971:Xanthinol Niacinate / Q000008:administration & dosage*
D014748:Vinca Alkaloids; D014815:Vitamins; D002936:Cinnarizine; D011343:Procaine; C013983:vinpocetine; D014971:Xanthinol Niacinate
Własne doświadczenia nad zachowawczym leczeniem zwyrodnienia środkowego siatkówki.